Literature DB >> 17254543

Regulation of protein phosphorylation within the MKK1-ERK2 complex by MP1 and the MP1*P14 heterodimer.

Amrita Brahma1, Kevin N Dalby.   

Abstract

MEK partner 1 (MP1) and P14 are small proteins that modulate the Raf-MKK1/2-ERK1/2 pathway. To examine the biochemical basis for their function a fluorescent form of MP1 was prepared by labeling Cys-74 with fluorescein. Using this protein it was shown that MP1 binds unactivated ERK1, ERK2 and a constitutively active form of MKK1 (MKK1G7B) with dissociation constants of 9.7+/-1.6, 3.3+/-0.6 and 2.2+/-0.5 microM, respectively. MP1 inhibits the ability of activated ERK2 to phosphorylate the transcription factor Ets-1. Both MP1 and the MP1*P14 complex inhibit the ability of activated ERK2 to phosphorylate MKK1G7B, thus impeding feedback inhibition. In contrast, MP1 and the P14*MP1 complex enhance the ability of MKK1G7B to phosphorylate ERK2, when ERK2 is present at a low concentration, but not when it is present at a high concentration. Thus, MP1 and the MP1*P14 complex have the potential to differentially modulate activating and inhibiting signals in the Raf-MKK1/2-ERK1/2 pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254543      PMCID: PMC2853909          DOI: 10.1016/j.abb.2006.11.031

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

Review 1.  Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs.

Authors:  Michiaki Kohno; Jacques Pouyssegur
Journal:  Prog Cell Cycle Res       Date:  2003

2.  The structure of the MAPK scaffold, MP1, bound to its partner, p14. A complex with a critical role in endosomal map kinase signaling.

Authors:  Vladimir V Lunin; Christine Munger; John Wagner; Zheng Ye; Miroslaw Cygler; Michael Sacher
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

3.  Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction.

Authors:  David Teis; Winfried Wunderlich; Lukas A Huber
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

5.  MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade.

Authors:  H J Schaeffer; A D Catling; S T Eblen; L S Collier; A Krauss; M J Weber
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1.

Authors:  S J Mansour; J M Candia; J E Matsuura; M C Manning; N G Ahn
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

7.  Crystal structure of the p14/MP1 scaffolding complex: how a twin couple attaches mitogen-activated protein kinase signaling to late endosomes.

Authors:  Robert Kurzbauer; David Teis; Mariana E G de Araujo; Sebastian Maurer-Stroh; Frank Eisenhaber; Gleb P Bourenkov; Hans D Bartunik; Mirko Hekman; Ulf R Rapp; Lukas A Huber; Tim Clausen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

8.  Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1).

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

9.  The threonine residues in MAP kinase kinase 1 phosphorylated by MAP kinase in vitro are also phosphorylated in nerve growth factor-stimulated rat phaeochromocytoma (PC12) cells.

Authors:  Y Saito; N Gomez; D G Campbell; A Ashworth; C J Marshall; P Cohen
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.

Authors:  A D Catling; H J Schaeffer; C W Reuter; G R Reddy; M J Weber
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  3 in total

1.  Stability of the endosomal scaffold protein LAMTOR3 depends on heterodimer assembly and proteasomal degradation.

Authors:  Mariana E G de Araújo; Taras Stasyk; Nicole Taub; Hannes L Ebner; Beatrix Fürst; Przemyslaw Filipek; Sabine R Weys; Michael W Hess; Herbert Lindner; Leopold Kremser; Lukas A Huber
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 2.  The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).

Authors:  Jing Sun; Guangxian Nan
Journal:  Int J Mol Med       Date:  2017-04-21       Impact factor: 4.101

3.  Erk1/2 MAP kinases are required for epidermal G2/M progression.

Authors:  Phillip A Dumesic; Florence A Scholl; Deborah I Barragan; Paul A Khavari
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.